Legend Biotech Corp (LEGN) stock
LEGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$16.11+0.12 (+0.75%)
Close on Nov 17, 2026Market cap $2.98BP/E –Yield –
Legend Biotech total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Legend Biotech's total debt was $156.40M at Jun 30, 2026. For fiscal 2025 it was $319.10M, up 5.9% from the year before. The highest annual figure on record is $319.10M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $319.10M | +5.9% |
| FY2024 | Dec 31, 2024 | $301.20M | +7.1% |
| FY2023 | Dec 31, 2023 | $281.33M | +7.8% |
| FY2022 | Dec 31, 2022 | $260.93M | +116.6% |
| FY2021 | Dec 31, 2021 | $120.46M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $156.40M | -49.6% |
| Q1 FY2026 | Mar 31, 2026 | $266.00M | -13.0% |
| Q4 FY2025 | Dec 31, 2025 | $319.10M | +5.9% |
| Q3 FY2025 | Sep 30, 2025 | $314.80M | +6.1% |
| Q2 FY2025 | Jun 30, 2025 | $310.26M | +6.4% |
| Q1 FY2025 | Mar 31, 2025 | $305.75M | +6.8% |
| Q4 FY2024 | Dec 31, 2024 | $301.20M | +7.1% |
| Q3 FY2024 | Sep 30, 2024 | $296.62M | +7.5% |
| Q2 FY2024 | Jun 30, 2024 | $291.56M | +7.7% |
| Q1 FY2024 | Mar 31, 2024 | $286.40M | +9.8% |
| Q4 FY2023 | Dec 31, 2023 | $281.33M | +133.5% |
| Q3 FY2023 | Sep 30, 2023 | $275.91M | +1493.9% |
| Q2 FY2023 | Jun 30, 2023 | $270.61M | – |
| Q4 FY2022 | Dec 31, 2022 | $260.93M | – |
| Q4 FY2021 | Dec 31, 2021 | $120.46M | – |
| Q2 FY2021 | Jun 30, 2021 | $17.31M | – |
See a number that looks wrong?